|
Research/Consulting
Services |
|
Abacus International - Independent healthcare consultancy specialising in health outcomes, strategic planning and medical communications |
|
Abt Bio-Pharma Solutions, Inc.
- A global provider of integrated health economic, commercialization and clinical solutions for the pharma, biotech, medical device and diagnostics industries. |
| |
Aegisnet - the
International Network for Health Care Research |
| |
AHP Research - AHP Research specialises in patient (and proxy) reported outcome (PRO) assessment, incorporating the patient's perspective into the development, delivery and evaluation of new treatments, technologies and healthcare interventions. AHP Research offers a client-focused approach to deliver consultancy, research and training for a range of clients from both public and private healthcare sectors. In addition to commissioned work, AHP Research takes a proactive approach to health research, initiating and collaborating on projects in several specialist areas to remain at the forefront of healthcare research and development |
| |
Analysis Group/Economics
- AnalysisGroup/Economics conducts cost of illness
and treatment impact STUDIES using data from Phase III and Phase IV clinical trials, administrative claims, epidemiological survey, and simulation models. |
| |
Analytica International is an independent global provider of clinical
and outcomes research, commercialization and communication services to the
pharmaceutical and biotechnology industries. |
|
The Bayesian Initiative in Health Economics & Outcomes Research
|
| |
BCN Health Economics & Outcomes Research S.L. is an independent healthcare consultancy that specializes in health outcomes, modeling, epidemiology, market access, RCT and observational study design, and medical writing. |
| |
BioMedCom Consultants Inc. - Biomedical, health
economic & health outcomes research application |
| |
Boston Health Economics, Inc.
- an independent research and consulting firm specializing in the economic evaluation of pharmaceuticals, medical devices, and disease management programs |
| |
Campbell
Alliance - Management Consultants in Pharmaceuticals and
Healthcare |
| |
Caro
Research - Proven Experience in Pharmacoeconomics, Epidemiology
and Technology Assessment |
| |
CEMKA Health Economics & Epidemiology |
| |
Centrum HTA - a consulting company involved in pharmacoeconomics |
| |
The Center for Pharmaceutical Outcomes Research at the University of North Carolina |
| |
Chinese PharmacoEconomics Guidelines Project -
Chinese Medical Doctor Association is the executive center of this project, and the center specializes in Chinese PharmacoEconomics Guidelines to improve the development of PharmacoEconomic assessment and clinical rational drug usage in China |
| |
Clinical Outcomes Research Group at The University of Georgia Medical College |
| |
Cornerstone Research Group Inc. - We are a research company, focused on maximizing the market success of our client’s products. We provide strategies and health economic research to identify, demonstrate and communicate product value. |
| |
Corporate
Translations, Inc. - A leading provider of translation and linguistic validation solutions, specializing in Quality of Life research instruments and clinical trail documents |
|
Dymaxium, Inc. - Dymaxium is a global provider of consulting solutions focused on maximizing the communication and application of clinical, economic, and humanistic outcomes research.
The AMCP eDossier System by Dymaxium. http://www.amcp.org/AMCPeDossierSystem/InformationKit.pdf
|
| |
Emory Center for Outcomes Research |
|
Epi Result in South Africa - Epi Result offers research consultancy quantitative research and epidemiology courses. The range of consultancy services that Epi Result offers is wide, including peer reviewing, study design (including systematic literature review), research project management, statistical analysis and publication writing. |
|
FormularyDecisions.Com |
|
Harvard School of Public Health |
| |
Hayes, Inc. - provides unbiased, evidence-based healthcare technology assessments and consulting. These reports inform hospitals, healthcare systems, government agencies, employers and managed care organizations about the strength of clinical evidence behind new technologies, compares the new technology with existing or future options, and evaluates the total cost of utilization. |
| |
Health Data Services Corporation -
database selection and
acquisition services from an
independent agent working with
top vendors of US and European
data. Services are free to
researchers |
| |
Health Decision Strategies
- for your health care decision software development needs |
| |
Health Promotion Research Inc.
- specializes in conducting scientific research into human behaviour as it relates to population health |
| |
Heron Evidence
Development Limited |
| |
HOPE Research Centre at the University of Toronto |
| |
InForMed GmbH -
Outcomes Research &
Health Economics |
| |
Infusion Pharma Consulting LLC -
Infusion’s Strategic
Pricing and Public
Policy practice
supports the
pharmaceutical and
biotech industries in
engineering,
evidencing and
capturing the value of
key product assets |
| |
Ingenix -
collaborates with
our clients on the
planning, execution,
and interpretation
of health care
research including
pharmacoeconomics,
health services, and
patient reported
outcomes research. |
| |
i3 Innovus We welcome you to visit the new i3 Innovus website to explore our full range of products and services in health economics and outcomes and market informatics |
| |
Institut de Recherche et d'Evaluation Médicale et Economique Faculté de Médecine Léonard de Vinci
|
| |
Institute for
Medical Technology
Assessment of the
Erasmus Medical
Centre Rotterdam,
The Netherlands
- conducts
fundamental and
applied research
into medical
technology
assessment (MTA) |
| |
Institute of
Health Economics
an Clinical
Epidemiology of
the University
of Cologne
|
| |
The
Institute of Health
Economics
- an
international
centre of
excellence in
health and
pharmaceutical
economics,
outcomes, and
policy
research,
based in
Edmonton,
Alberta. The
work of the
IHE in
research and
research
methodologies,
policy
analyses,
education and
training, and
knowledge
transfer
contributes to
the efficient
and effective
use of health
care
resources. A
not-for-profit
organization,
the IHE is
distinguished
by a
university-government-industry
partnership,
and by the
affiliation of
34 world-class
research
fellows. |
| |
Janssen-Cilag |
|
JestaRx - providing solutions all the way from strategic planning, through advisory boards, market research, retrospective and prospective data analysis, and on to presentations, manuscripts, and posters. |
| |
Katalyst Health
Technology Assessments - designs
and conducts
health
outcomes
analyses and
develops
custom
software tools
for sales and
market access
applications. |
|
Kleijnen Systematic Reviews Ltd – for Systematic Reviews, Health Technology Assessments, Guidelines, Training, Consultancy, Critical Appraisal Service |
|
Mapi Research Institute (MRI) - is an international company with a special interest in advancing the worldwide use of patient-reported and clinical assessments through linguistic validation of PRO instruments for appropriate cross-cultural use and interpretation. |
| |
Mapi Values
-
specialist in
health
economic,
quality of
life and
patient
satisfaction
studies. |
| |
Matrix45
-
Evidence-based
healthcare
-
consulting
and
science
...
serving
the
pharmaceutical,
biotechnology,
and
private/academic
research
sectors
...
strategic,
scientific,
and
analytical
consulting
with the
services
to
support
it ...
Phase 4
and 5 in
biopharma
- and
development
in
private/academic
research
... at
the
interface
of
strategy,
science,
and
change
....
science
for a
purpose. |
| |
McKesson - providing assistance to hospitals in the implementation of revenue cycle solutions to extend the capabilities of hospital information systems. |
| |
Medical Decision Modeling Inc – a research and consulting firm specializing in the development of software-based cost effectiveness, budget impact, and disease state models for the healthcare industry. |
|
Monteban Outcomes Research Consultancy – Specialised in Outcomes Research and Market Access services for all stages of product development. |
|
Nordic Health Economic Research AB - Independent consultancy and research company specializing in economic evaluations and outcomes research in the Nordic countries. |
|
Office of Health Policy and Clinical Outcomes (Thomas Jefferson University, Philadelphia) |
|
Oxford Outcomes
- an international outcomes research agency specialising in Quality of Life (QoL) research
|
|
Outcomes Research - medical research to guide clinical decisions |
|
Ovation Research Group - an independent health economics and outcomes research and consulting firm |
|
Pharmaceutical
Outcomes Research and Policy Program at The University of Washington Department of Pharmacy |
|
Pharmaceutical Economics and Policy (University of Southern California) |
| |
Pharmacotherapy Outcomes Research Center - A research, education, and service organization that conducts and interprets studies to improve patient care through optimal drug therapy. |
|
PharmIdeas - is committed to making your project a success story. Over the past 15 years, we have dedicated ourselves to broadening our knowledge and know-how to cover the full range of health technology assessment expertise: prospective, retrospective and predictive health economic evaluations and outcomes research studies, evidence-based systematic reviews and meta-analyses, health policy projects and reimbursement value dossiers. We have also developed our own proprietary electronic QoL tool for PROs. In addition, PharmIdeas has developed a diverse, extensive and international network of offices and collaborators which enables us to adapt our approach to any challenge. Listening to the customer’s needs, we provide the highest quality products and services, in a spirit of constant improvement, respect of guidelines as well as timelines, open-mindedness and transparency. Our view is to offer our clients customized solutions for their healthcare research needs with deliverables of superior quality. |
|
PharMerit - delivers state-of-the-art European pharmacoeconomic evaluations to international pharmaceutical, biotech and medical device industries. Services offered include environmental scans, modelling studies, costing
studies, care mapping and reimbursement support. |
|
PHARMO Institute - PHARMO is a scientific research organization dedicated to study the efficiency, safety and cost-effectiveness of drugs in daily practice |
| |
Polaris Health Directions - develops automated outcomes systems
for a variety of healthcare environments, including mental health and
chemical dependency as well as the screening and monitoring of depression
and anxiety in primary care and other medical settings. |
|
Policy Analysis Inc. - a contract-research and consulting group performing health-economic and quality-of-life evaluations for a variety of pharmaceutical and biotech companies |
| |
RTI Health Solutions - provides a broad range of responsive, comprehensive services that can help you to assess the population impact and value of your product throughout its lifecycle. |
| |
Scandinavian Outcomes -
Scandinavian Outcomes is a leading provider of innovative outcomes research services in Scandinavia. We deliver relevant analyses - with local insight and real world impact - across the life cycle of our client's medicinal products and health care interventions. We are dedicated to providing support to our clients in improving the health care industry, with focus on the patient. |
| |
Therapeutic Management, Inc (TTM) -TTM provides medical chart review services to research organizations and pharmaceutical companies that conduct outcomes research. Over the last 10 years, TTM has established itself as the premier chart review company, conducting over 250,000 medical chart reviews extracting valuable outcome data for research purposes or quality improvement. TTM specializes in extracting data from manual or electronic charts in any location or format. |
| |
UPM Inc. -
Research in drug development: Research is a must in drug development services for the
unconventional diseases in today's world. |
| |
United BioSource Corporation (former Medtap) |
|
University of Bayreuth list of other health economic WEB sites |
|
University of Arizona Center for Health Outcomes and Pharmacoeconomic Research (HOPE) |
|
University of Texas School of Public Health, Houston Outcomes Research |
|
University of York Health Economics for Health Care Professionals |
|
The Weinberg Group, Inc. |
|
TreeAge Software - Decision Analysis, Decision Trees. Our powerful decision tree / decision analysis software helps you: * Model problems as decision trees, Markov models or influence diagrams.
* Analyze decision based models & make better decisions using expected value calculations, cost-effectiveness analysis, probabilistic sensitivity analysis and Monte Carlo simulation.
* Communicate results interactively, including recommended strategy, cost-effective options, underlying analysis, best decisions and supporting assumptions. |
| |
Xcenda (former Applied Health Outcomes) - Xcenda is a leading health economics and outcomes research consultancy that includes an integrated, full-service managed markets agency. Our team is composed of health economists, data analysts, clinicians, and scientists along with experienced marketers, reimbursement strategists, and market research experts. We help pharmaceutical, biotech, and medical device companies quantify, validate, and communicate the clinical and economic value of their products. Our areas of specialization include retrospective database studies, budget impact and cost-effectiveness models, prospective studies, and outcomes analyzers. Xcenda partners with manufacturers to maximize patient access and optimize commercial success across all phases of the product life cycle. Because we are an AmerisourceBergen Specialty Group company, our clients benefit from significantly greater access to the comprehensive resources needed to successfully launch, market, support, and distribute pharmaceuticals within the specialty and oncology markets. |
|
TO TOP |
| Not for Profit Organizations |
|
AcademyHealth
|
|
The Canadian Association for Population Therapeutics |
|
"College des Economistes de la Sante" (French Health Economists Association) |
|
Doctors for Chile |
|
ESCP-The European Society of Clinical Pharmacy |
|
Harvard School of Public Health |
|
Health Economics Association of Spain |
|
Institute for Clinical and Economic Review (ICER) - ICER is an academic technology assessment initiative based at Massachusetts General Hospital and affiliated with Harvard Medical School. Informed by priorities of payers, clinicians, and patients, and based at arms’ length from coverage decision-making structures in government and the private sector, ICER links clinical effectiveness and comparative value together in a rating system that is consistent and rigorous, yet flexible enough to be directly useful to multiple decision makers. |
|
Institut Belge de l'economie de la Sante asbl |
|
International Society for Quality of Life Research |
|
Mapi Research Trust - is a non-profit organization advancing the art and the use of scientific approaches to Patient-Reported Outcome (PRO) measures. Its aim is to exchange health outcomes information and experiences among all people involved in PROs. It also encourages the development and implementation of collaborative research by collecting, analyzing and distributing Patient-Reported instruments and organizing educational programs in the field. |
|
Pharmacoethics - dedicated to the exploration of ethical issues related to the development, promotion, sales, prescription, and use of pharmaceuticals |
|
REES France (Réseau d'Evaluation en Economie de la Santé) - is a French consulting firm specialized in the evaluation of new health care technologies, design of epidemiological researches, data collection using Internet and the development of specific quality of life scale. Biostatistical, economics and computer science skills are mobilized within mathematical models to predict consequences of new drugs or health care practices. |
|
Society for Medical Decision Making |
|
TO TOP |
| Internet Services |
|
AHP Research – This resource page contains useful information on research methods, reviews of outcomes research books, important links, newsletters and more. |
|
EudraNet - Network services for the EU Pharmaceutical Regulatory Sector |
| |
HealthEconomics.com Health Economics, Medical and Pharmacy Resources by Category |
|
The Guide to Health Economics, Medical and Pharmacy Resources |
| |
Health Decision Strategies
- for your health care decision software development needs
|
|
Medscape - online health record, news and information resource |
|
TO TOP |
| Journals/Publications |
|
Clinical Therapeutics, Pharmaceutical Economics & Health Policy
--
The International Peer-Reviewed Journal of Drug Therapy |
| |
Health Affairs - The Policy Journal of the Health Sphere |
| |
Health Economics |
|
PharmacoEconomics (Journal) |
| |
Pharmacoepidemiology and Drug Safety |
|
TO TOP |
| NGO – Government-Quasi-Government Services |
|
Canadian Coordinating Office of Health Technology
Assessment |
|
Cochrane Collaboration Home Page |
|
EUCOMED - represents the Medical Technologies Industry in Europe |
|
The United States Food & Drug Administration (FDA) |
|
GPO Gate - the University of California's gateway to federal information |
|
Health Economics at the World Health Organization (WHO) |
|
The United States Centers for Disease Control and Prevention |
|
The United States Department of Health and Human Services |
|
The United States National Library of Medicine |
|
World Bank |
|
TO TOP |
| Database Services |
| |
Health Data Services Corporation – database selection and
acquisition services from an
independent agent working with
top vendors of US and European
data. Services are free to
researchers |
|
Health Economic Evaluations Database (HEED) |
|
Protocare Sciences |
|
TO TOP |
| Academic Institution |
| |
Institute for Clinical and Economic Review (ICER) - ICER is an academic technology assessment initiative based at Massachusetts General Hospital and affiliated with Harvard Medical School. Informed by priorities of payers, clinicians, and patients, and based at arms’ length from coverage decision-making structures in government and the private sector, ICER links clinical effectiveness and comparative value together in a rating system that is consistent and rigorous, yet flexible enough to be directly useful to multiple decision makers. |
| |
University of Illinois at Chicago - Center for Pharmacoeconomic Research |
|
University of Maryland Graduate Program in Pharmacy Administration |
|
University of Texas at Austin College of Pharmacy |
|
University of Utah Department of Pharmacotherapy |
|
The Wharton School at The University of Pennsylvania |
|
West Virginia University Department of Pharmaceutical Systems and Policy |
|
TO TOP |
